NTNikolay V. Tsvetov

Nikolay V. Tsvetov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nikolay V. Tsvetov has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular senescence in cartilage and bone tissue aging: role in disease development and therapeutic potential

    by Natalia G. Plekhova, Polina A. Novikova, Nikolay V. Tsvetov, Плехова Наталья Геннадьевна, Цветов Николай Владимирович

    Cellular senescence induced by various types of stress leads to irreversible cell cycle arrest and alterations in gene expression, metabolism, chromatin organization, and activation of anti-apoptotic signaling pathways. This process results in the formation of a pro-inflammatory secretome, known as the senescence-associated secretory phenotype, which triggers chronic sterile inflammation (inflammaging). This review summarizes current evidence on the role of cellular senescence in age-related changes and diseases of the joints and skeletal system, as well as potential therapeutic strategies. Based on an articles search in the Google Scholar, PubMed (MEDLINE), Scopus, and Web of Science databases using specific keywords and their combinations and the AMSTAR 2 methodology, this review presents the role of cellular senescence in age-related changes and diseases of the joints and skeletal system. Data are presented demonstrating the presence of senescent cells with a senescence-associated secretory phenotype expressing the p16Ink4a protein in the microenvironment of cartilage and bone tissue. It was demonstrated that with advancing age, stem and progenitor cells, osteoblasts, osteocytes, and chondrocytes express senescence markers and acquire characteristic aging-associated traits such as genomic instability, telomere shortening, epigenetic modifications, proteostasis loss, and mitochondrial dysfunction. It has been demonstrated that cellular senescence and the development of the secretory phenotype are causally linked to chronic inflammation and contribute to the development of osteoporosis and osteoarthritis. A new strategy for the treatment of osteoporosis and osteoarthritis—senotherapy—is presented, in which the therapeutic targets are senescent cells (senolytics) or various mechanisms responsible for their survival and transformation into the senescence-associated secretory phenotype (senomorphics). Evidence shows that advances in senescence research over the past decade have laid the groundwork for novel therapeutic approaches targeting joint and bone diseases. Further investigation of the endocrine activity of senescence-associated secretory phenotype cartilage and bone cells is needed to provide the basis for understanding interactions among different systems of the aging organism and for developing strategies for the simultaneous treatment of age-related disorders.